| Session Date | Particulars |
| 14 October, 2024 | Review of current guidelines on palliative sedation |
| 21 October, 2024 | Review of current recommendations on management of diabetes mellitus at end of life |
| 28 October, 2024 | Review of evidence for managing pruritus in patients receiving palliative care |
| 4 November, 2024 | Review of evidence on blood and blood component transfusion at end of life |
| 11 November, 2024 | Review of evidence on serious-health related suffering internationally and in India |
| 18 November, 2024 | Review of guidelines and evidence on use of octreotide in a palliative care setting |
| 25 November, 2024 | Evidence-based approaches for deprescribing in patients with advanced cancer receiving palliative care |
| 2 December, 2024 | Evidence-based guidelines on prevention and management of pressure sores |
| 9 December, 2024 | Evidence for various pharmacological strategies used in management of breakthrough cancer pain |
| 16 December, 2024 | Guidelines and evidence for treating hypercalcemia of malignancy in adults |
| 23 December, 2024 | Current recommendations, evidence and guidelines on management of chemotherapy induced peripheral neuropathy |
| 30 December, 2024 | Evidence of early integration of palliative care in oncological illnesses based on findings of systematic reviews |
| 6 January, 2025 | Evidence, guidelines and recommendations on the role of Direct oral anticoagulants (DOAC) in Cancer thrombosis |
| 13 January, 2025 | Evidence on pharmacogenomics of Opioid analgesics and its clinical implications |
| 20 January, 2025 | Evidence and recommendations regarding assessing suicide risk in a patient receiving palliative care |
| 27 January, 2025 | Review of evidence on the role of palliative care in the setting of cardiac transplantation |
10 February, 2025
(3 Feb break after IAPCON) | Current guidelines and evidence on Palliative Oxygen Therapy |
| 17 February, 2025 | Review of current evidence regarding the use of opioids for managing breathlessness |
| 24 February, 2025 | MORE care statement on best methods to research in end-of-life care and its implementation |
| 3 March, 2025 | Clinical practice guidelines and evidence for venous thromboembolism prophylaxis and treatment in a palliative care setting |
| 10 March, 2025 | Evidence-based strategies to reduce caregiver burnout |
| 17 March, 2025 | Evidence on role of narrative medicine in palliative care |
| 24 March, 2025 | Evidence supporting the use of music therapy for symptom management in a palliative care setting |
7 April, 2025
| Embedded model of palliative care delivery and evidence to support this practice |
| 21 April, 2025 | Compassion fatigue among palliative care providers and evidence-based strategies to mitigate it |
28 April, 2025
| Evidence and recommendations on palliative prescribing in patients with parkinsonism |
5 May, 2025
| Fast-track trials in palliative care |
| 19 May, 2025 | Evidence-based management strategies for managing anorexia and fatigue |
| 26 May, 2025 | Evidence on the role of metronomic chemotherapy in a palliative care setting |
| 2 June, 2025 | Evidence and current recommendations regarding artificial nutrition at end of life |
| 9 June, 2025 | Evidence-based management of myiasis |
| 16 June, 2025 | Current recommendations and evidence for discontinuing LVADs in a palliative care setting |
| 23 June, 2025 | Current evidence and recommendations for using mirtazapine in a palliative care setting |
| 30 June, 2025 | Evidence, current recommendations, and management strategies for opioid-induced hyperalgesia |
| 7 July, 2025 | Evidence-based management of diarrhoea in a palliative care setting |
| 14 July, 2025 | Evidence for Methylphenidate and Modafinil in a palliative care setting |
| 21 July, 2025 | Evidence and recommendations for using novel adjuvants used in the management of bone pain |
| 28 July, 2025 | Evidence-based consensus on the stepwise management of this patient’s neuropathic pain |
| 4 August, 2025 | Evidence on the role of Point of Care Ultrasound (POCUS) in a palliative care setting |
| 11 August, 2025 | Evidence on the concept of Time Toxicity during management of patients needing palliative care |
| 18 August, 2025 | Evidence on the role of Ketamine in management of depression in a palliative care setting |
| 25 August, 2025 | Evidence on the role of Dexmedetomidine for hyperactive delirium at the end of life |
| 1 September, 2025 | Evidence for Morphine in management of Chronic Breathlessness Syndrome |
| 8 September, 2025 | Evidence on the role of hormonal therapies in patients with advanced cancer |
| 15 September, 2025 | Evidence supporting the use of methylnaltrexone in opioid induced constipation |
| 22 September, 2025 | Evidence for parenteral adjuvant analgesia for managing neuropathic pain |
| 29 September, 2025 | Evidence for prognostication and prediction of mortality in end stage heart failure |
| 6 October, 2025 | Evidence-based frameworks that can aid in establishing care goals and effective communication |
| 13 October, 2025 | Evidence on life-review interventions and its role in palliative care setting |
27 October, 2025
| Evidence on Quality Adjusted Life Years and its application in a palliative care setting |
| 3 November, 2025 | Evidence on barriers for palliative care referrals in patients with cancer based on findings of systematic reviews |
| 10 November, 2025 | Evidence-based strategies for effectively communicating potentially traumatic events to children |
